Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
STOCKS
Moleculin Shares Jump on Progress With Virus-Drug Candidate
By Rob Lenihan
Jul 21, 2020 9:36 AM EDT
PRESS RELEASES
Moleculin Engages IQVIA To Manage Potential COVID-19 Clinical Trial
By PR Newswire
Apr 6, 2021 7:30 AM EDT
PRESS RELEASES
Moleculin Receives FDA Approval Of Fast Track Designation For Annamycin In The Treatment Of Sarcoma Lung Metastases
By PR Newswire
Mar 30, 2021 7:30 AM EDT
PRESS RELEASES
Moleculin Announces Full Exercise Of Over-Allotment Option
By PR Newswire
Feb 10, 2021 4:15 PM EST
PRESS RELEASES
Moleculin Announces Grant Awarded To Polish Research Institute For Independent Clinical Trial Of Annamycin In Sarcoma Lung Metastases
By PR Newswire
Feb 8, 2021 7:30 AM EST
PRESS RELEASES
Moleculin Announces Pricing Of $67.8 Million Underwritten Public Offering
By PR Newswire
Feb 3, 2021 8:30 AM EST
PRESS RELEASES
Moleculin Announces Proposed Underwritten Public Offering
By PR Newswire
Feb 2, 2021 4:22 PM EST
PRESS RELEASES
Moleculin Signs Agreement With Catalyst Clinical Research To Begin Sarcoma Trial
By PR Newswire
Feb 1, 2021 7:30 AM EST
PRESS RELEASES
Moleculin Announces Reverse Stock Split
By PR Newswire
Jan 29, 2021 9:15 AM EST
PRESS RELEASES
Moleculin Announces Annamycin Receives FDA Orphan Drug Designation For Soft Tissue Sarcomas
By PR Newswire
Dec 29, 2020 7:30 AM EST
PRESS RELEASES
Moleculin Announces FDA Permission To Begin Clinical Study Of Annamycin For Sarcoma Lung Metastases
By PR Newswire
Dec 17, 2020 7:30 AM EST
PRESS RELEASES
Moleculin To Present Antitumor Activity Of Annamycin In Combination With Ara-C In AML At American Society For Hematology Annual Conference
By PR Newswire
Dec 3, 2020 7:30 AM EST
PRESS RELEASES
Moleculin Announces FDA Approves 3 Rare Pediatric Disease Designations For WP1066
By PR Newswire
Dec 1, 2020 7:30 AM EST
PRESS RELEASES
Moleculin Announces New Data Demonstrating Synergistic Antitumor Activity Of Annamycin Combination With Ara-C In AML
By PR Newswire
Nov 19, 2020 7:30 AM EST
PRESS RELEASES
Moleculin Announces Additional Collaboration On Drug Candidate Targeting COVID-19
By PR Newswire
Oct 29, 2020 7:30 AM EDT
PRESS RELEASES
Moleculin Announces Independent Study Validates Annamycin's Ability To Target Lung Localized Tumors
By PR Newswire
Oct 21, 2020 7:30 AM EDT
PRESS RELEASES
Moleculin Announces Additional Positive Interim Results In Adult Glioblastoma Clinical Trial
By PR Newswire
Oct 13, 2020 7:30 AM EDT
PRESS RELEASES
Moleculin Announces New Antiviral Drug Candidates Demonstrate In Vitro Activity Against HIV
By PR Newswire
Oct 6, 2020 7:30 AM EDT
PRESS RELEASES
Moleculin Announces Discovery Of Significant In Vitro Activity Against COVID-19 Virus For New Antimetabolites
By PR Newswire
Sep 29, 2020 7:30 AM EDT
PRESS RELEASES
Moleculin Announces COVID-19 In Vivo Testing Contracted For WP1122
By PR Newswire
Sep 14, 2020 7:30 AM EDT
PRESS RELEASES
Moleculin To Present At Upcoming Healthcare Investor Conferences
By PR Newswire
Sep 10, 2020 7:30 AM EDT
PRESS RELEASES
BRK Extends Its Footprint Into Europe And CIS And "EV" Vehicles With Key Appointment
By PR Newswire
Sep 9, 2020 1:52 PM EDT
PRESS RELEASES
Moleculin Announces Successful Completion Of Pre-IND Meeting With The FDA
By PR Newswire
Sep 9, 2020 7:30 AM EDT
PRESS RELEASES
Additional Independent Research Further Supports Glucose Metabolism As Important COVID-19 Target
By PR Newswire
Jul 29, 2020 7:30 AM EDT
STOCKS
Moleculin Shares Jump on Progress With Virus-Drug Candidate
By Rob Lenihan
Jul 21, 2020 9:36 AM EDT
